Dow Down 0.05% Nasdaq Up 0.52%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
6.99 Up 0.47(7.13%) 11:38AM EST - Nasdaq Real Time Price
Prev Close:6.52
Open:6.76
Bid:6.92 x 3500
Ask:6.93 x 2600
1y Target Est:8.28
Beta:0.78
Earnings Date:Feb 23 - Feb 27 (Est.)
Day's Range:6.74 - 7.24
52wk Range:3.80 - 9.83
Volume:10,347,401
Avg Vol (3m):6,368,940
Market Cap:1.31B
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIAUp 7.13%1.31B
NVSDown 0.21%229.25B
PFEDown 0.43%191.04B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):26.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.10
Quarterly EPS Est (Dec-14) :-0.27
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback